Veterinary Medicines

NOBILIS RHINO CV

Authorised
  • Turkey rhinotracheitis virus, strain 11/94, Live
Download as PDF

Product identification

Medicine name:
NOBILIS RHINO CV
NOBILIS RHINO CV LYOPHILISAT POUR SUSPENSION OCULO-NASALE POUR POULES
Active substance:
  • Turkey rhinotracheitis virus, strain 11/94, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Nasal use
  • Ocular use
  • Nebulisation use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 11/94, Live
    1.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Nebulisation use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses
  • Cardboard box containing 50 glass (Type I) vials of 250 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5254932 2/2004
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0151/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 21/05/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 21/05/2025
Download